We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


ZixEnable Is Selected by ICON Central Laboratories to Encrypt Laboratory Results

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ZixEnable Is Selected by ICON Central Laboratories to Encrypt Laboratory Results"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Zix Corporation (ZixCorp), a leader in email encryption services, was selected by ICON Central Laboratories to provide lab reports through an encrypted email solution for select sites participating in clinical trials. ICON Central Laboratories, a division of ICON plc, is a global central laboratory exclusively engaged in clinical trial testing. With laboratories located in New York, Dublin, Singapore, India and China, ICON Central Laboratories has tested and reported lab results for clinical trial subjects in more than 40,000 sites worldwide.

ICON Central Laboratories tracks patient results using ICOLIMS, a state-of-the-art laboratory information management system. Once recorded, ICOLIMS automatically sends patient results through ZixEnable(SM), an application-generated email encryption service. With ZixEnable, patient results are delivered securely 24/7 worldwide, enabling physicians to better monitor and adjust patient treatment during clinical trials.

"The use of ICOLIMS in conjunction with ZixEnable provides more efficient results to physicians, increases patient safety and enhances the research environment for our sponsors," said John Reinert, Vice President of Information Technology and Global Data Services for ICON Central Laboratories. "With encrypted email through ZixCorp, we can confidently send results to our global clinical sites around the clock through our automated processes. We also benefit from knowing the right clinical teams are accessing the appropriate data and that physicians can access the electronic information as much as needed."

The pharmaceutical research industry has traditionally used fax machines to deliver patient results to clinical sites. The most significant challenges in faxing patient results are the inability to reach all clinical sites and the inability of physicians to manage the information electronically.

Physicians who use ZixGateway(R), a policy-based email encryption appliance, receive patient results transparently in their inbox, requiring no extra steps or passwords to access the encrypted email. Physicians without ZixGateway receive encrypted email through ZixPort(R), a secure Web portal. Regardless of delivery method, ICON Central Laboratories receives reports on who has received and opened the encrypted email.

"Application-generated encrypted email through ZixEnable is yet another example of the power of secure email and the innovation ZixCorp brings to the market," said Rick Spurr, ZixCorp's Chairman and Chief Executive Officer. "Automatic secure email is a strategic platform that many companies in the pharmaceutical, healthcare and financial industries can leverage to reach targeted audiences in real-time and meet regulatory requirements for secure data transmission. We appreciate ICON Central Laboratories' trust in using our solution to send sensitive patient data."